Publikationen, an denen er mitarbeitet Santiago Moreno Guillén (22)

2024

  1. Acceptability of Long-Acting Injectable Antiretroviral Treatment for HIV Management: Perspectives of Patients and Physicians in Spain

    AIDS Patient Care and STDs, Vol. 38, Núm. 7, pp. 305-314

  2. Should we measure quality of life among people with HIV? A multicentre survey of physicians' opinions in Spain

    HIV Medicine

2022

  1. Discovering HIV related information by means of association rules and machine learning

    Scientific Reports, Vol. 12, Núm. 1

  2. Predictors of low-level HIV viraemia and virological failure in the era of integrase inhibitors: A Spanish nationwide cohort

    HIV Medicine, Vol. 23, Núm. 8, pp. 825-836

2021

  1. COVID-19 in hospitalized HIV-positive and HIV-negative patients: A matched study

    HIV Medicine, Vol. 22, Núm. 9, pp. 867-876

2020

  1. Effectiveness of the combination elvitegravir/cobicistat/tenofovir/emtricitabine (EVG/COB/TFV/FTC) plus darunavir among treatment-experienced patients in clinical practice: A multicentre cohort study

    AIDS Research and Therapy, Vol. 17, Núm. 1

  2. Effects of first-line antiretroviral therapy on the CD4/CD8 ratio and CD8 cell counts in CoRIS: a prospective multicentre cohort study

    The Lancet HIV, Vol. 7, Núm. 8, pp. e565-e573

  3. How well are we performing the initial assessment of HIV-positive patients? Results from a multicentre cohort in Spain

    HIV Medicine, Vol. 21, Núm. 2, pp. 128-134

  4. The algorithm used for the interpretation of doravirine transmitted drug resistance strongly influences clinical practice and guideline recommendations

    The Journal of antimicrobial chemotherapy, Vol. 75, Núm. 5, pp. 1294-1300

2008

  1. Didanosine, lamivudine, and efavirenz versus zidovudine, lamivudine, and efavirenz for the initial treatment of hiv type 1 infection: Final analysis (48 weeks) of a prospective, randomized, noninferiority clinical trial, GESIDA 3903

    Clinical Infectious Diseases, Vol. 47, Núm. 8, pp. 1083-1092

2005

  1. Nosocomial bloodstream infections caused by Streptococcus pneumoniae

    Clinical Microbiology and Infection, Vol. 11, Núm. 11, pp. 919-924

2004

  1. Therapeutic immunization with an inactivated HIV-1 Immunogen plus antiretrovirals versus antiretroviral therapy alone in asymptomatic HIV-infected subjects

    Vaccine, Vol. 22, Núm. 23-24, pp. 2966-2973

2001

  1. Erupción papulosa aislada y confluente en tronco y manos en varón con infección por el virus de la inmunodeficiencia humana

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 19, Núm. 7, pp. 339-340

  2. Fiebre prolongada y dolor en hipocondrio derecho en paciente anciana

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 19, Núm. 3, pp. 125-126

  3. Occupational exposures to blood-borne pathogens in health care workers

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 19, Núm. 4, pp. 156-160

  4. The effect of BCG vaccination on tuberculin reactivity and the booster effect among hospital employees

    Archives of Internal Medicine, Vol. 161, Núm. 14, pp. 1760-1765

  5. Tratamiento de las infecciones oportunistas en pacientes adultos y adolescentes infectados por el virus de la inmunodeficiencia humana en la era del tratamiento antirretrovírico de gran actividad

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 19, Núm. 8, pp. 376-392

  6. Treatment of tuberculosis in HIV-infected patients: Safety and antiretroviral efficacy of the concomitant use of ritonavir and rifampin

    AIDS, Vol. 15, Núm. 9, pp. 1185-1187

  7. Varón con fiebre, dolor y limitación funcional del hombro derecho

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 19, Núm. 5, pp. 229-230

1999

  1. Invasive disease caused by ciprofloxacin-resistant uropathogenic Escherichia coli

    European Journal of Clinical Microbiology and Infectious Diseases, Vol. 18, Núm. 7, pp. 503-505